Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.

Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAn NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” while the site revision advances from v3.7.1 to v3.7.2. The study record itself remains a 403 error page.SummaryDifference1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0; the page remains a 403 error page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-restricted message.SummaryDifference18%

- Check43 days agoChange DetectedThe page shows a new revision label, v3.7.0, replacing the previous v3.6.6. This update reflects an internal platform upgrade and does not change the study content or public information visible on the page.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now displays Revision: v3.6.6 instead of v3.6.5, indicating a minor update to the page metadata rather than substantive changes to the study details.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page’s revision label was updated from v3.6.4 to v3.6.5, representing a small maintenance update to the page version rather than a substantive change to the study details.SummaryDifference0.1%

Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.